SEARCH

SEARCH BY CITATION

References

  • 1
    Newman ME, Gur E, Shapira B, Lerer B. Neurochemical mechanisms of action of ECS: Evidence from in vivo studies. J. ECT 1998; 14: 153171.
  • 2
    Mann JJ. Neurobiological correlates of the antidepressant action of electroconvulsive therapy. J. ECT 1998; 14: 172180.
  • 3
    Gravenstein JS, Anton AH, Wiener SM, Tetlow AG. Catecholamine and cardiovascular response to electro-convulsion therapy in man. Br. J. Anaesth. 1965; 37: 833839.
  • 4
    Mulgaokar GD, Dauchot PJ, Duffy JP, Anton AH. Noninvasive assessment of electroconvulsive-induced changes in cardiac function. J. Clin. Psychiatry 1985; 46: 479482.
  • 5
    Abrams R. Electroconvulsive Therapy. Oxford University Press, New York, 2002.
  • 6
    Lewis WH, Jr, Richardson DJ, Gahagan LH. Cardiovascular disturbances and their management in modified electrotherapy for psychiatric illness. N. Engl. J. Med. 1955; 252: 10161020.
  • 7
    Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. [Myocardial stunning due to simultaneous multivessel coronary spasms: A review of 5 cases]. J. Cardiol. 1991; 21: 203214.
  • 8
    Cristancho MA, Satterthwaite TD, O'Reardon JP. Cardiac complications of ECT: Myocardial stunning syndrome and takotsubo cardiomyopathy after ECT: Different names for the same phenomenon. J. ECT 2010; 26: 146147.
  • 9
    Kent LK, Weston CA, Heyer EJ, Sherman W, Prudic J. Successful retrial of ECT two months after ECT-induced takotsubo cardiomyopathy. Am. J. Psychiatry 2009; 166: 857862.
  • 10
    Ito M, Hatta K, Miyakawa K, Miyauchi K, Arai H. Prolonged and fluctuating giant T-wave inversion after electroconvulsive therapy. J. ECT 2007; 23: 194197.
  • 11
    Faris R, Purcell H, Henein MY, Coats AJ. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur. J. Heart Fail. 2002; 4: 541551.
  • 12
    Vaccarino V, Kasl SV, Abramson J, Krumholz HM. Depressive symptoms and risk of functional decline and death in patients with heart failure. J. Am. Coll. Cardiol. 2001; 38: 199205.
  • 13
    Jiang W, Alexander J, Christopher E et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch. Intern. Med. 2001; 161: 18491856.
  • 14
    Gold PW, Wong ML, Goldstein DS et al. Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc. Natl Acad. Sci. U.S.A. 2005; 102: 83038308.
  • 15
    Benedict CR, Shelton B, Johnstone DE et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 1996; 94: 690697.
  • 16
    Francis GS, Benedict C, Johnstone DE et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990; 82: 17241729.
  • 17
    Anand IS, Fisher LD, Chiang YT et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107: 12781283.
  • 18
    Kelly CB, Cooper SJ. Plasma noradrenaline response to electroconvulsive therapy in depressive illness. Br. J. Psychiatry 1997; 171: 182186.
  • 19
    Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967; 6: 278296.
  • 20
    Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987; 13: 261276.
  • 21
    Krystal AD, Coffey CE, Weiner RD, Holsinger T. Changes in seizure threshold over the course of electroconvulsive therapy affect therapeutic response and are detected by ictal EEG ratings. J. Neuropsychiatry Clin. Neurosci. 1998; 10: 178186.
  • 22
    Suppes T, Rush AJ. Medication optimization during clozapine treatment. J. Clin. Psychiatry 1996; 57: 307308.
  • 23
    Krystal AD, Weiner RD, Coffey CE. The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT. J. Neuropsychiatry Clin. Neurosci. 1995; 7: 295303.
  • 24
    Krystal AD, Weiner RD. ECT seizure therapeutic adequacy. Convuls. Ther. 1994; 10: 153164.
  • 25
    Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J. EEG manifestations during ECT: Effects of electrode placement and stimulus intensity. Biol. Psychiatry 1993; 34: 321330.
  • 26
    Welch CA, Drop LJ. Cardiovascular effects of ECT. Convuls. Ther. 1989; 5: 3543.
  • 27
    Rasmussen KG, Karpyak VM, Hammill SC. Lack of effect of ECT on Holter monitor recordings before and after treatment. J. ECT 2004; 20: 4547.
  • 28
    Cassidy F, Weiner RD, Cooper TB, Carroll BJ. Combined catecholamine and indoleamine depletion following response to ECT. Br. J. Psychiatry 2010; 196: 493494.
  • 29
    Linnoila M, Karoum F, Rosenthal N, Potter WZ. Electroconvulsive treatment and lithium carbonate. Their effects on norepinephrine metabolism in patients with primary, major depressions. Arch. Gen. Psychiatry 1983; 40: 677680.
  • 30
    Linnoila M, Karoum F, Potter WZ. Effects of antidepressant treatments on dopamine turnover in depressed patients. Arch. Gen. Psychiatry 1983; 40: 10151017.
  • 31
    Cooper SJ, Leahey W, Green DF, King DJ. The effect of electroconvulsive therapy on CSF amine metabolites in schizophrenic patients. Br. J. Psychiatry 1988; 152: 5963.
  • 32
    Serby MJ, Lantz M, Chabus BI, Bernay LJ. Takotsubo cardiomyopathy and electroconvulsive treatments: A case study and review. Int. J. Psychiatry Med. 2010; 40: 9396.
  • 33
    Satterthwaite TD, Cristancho MA, Alici Y, Weiss D, O'Reardon JP. Electroconvulsive therapy in a 72-year-old woman with a history of Takotsubo cardiomyopathy: A case report and review of the literature. Brain Stimul 2009; 2: 238240.
  • 34
    Ueyama T, Kasamatsu K, Hano T, Yamamoto K, Tsuruo Y, Nishio I. Emotional stress induces transient left ventricular hypocontraction in the rat via activation of cardiac adrenoceptors: A possible animal model of ‘tako-tsubo’ cardiomyopathy. Circ. J. 2002; 66: 712713.
  • 35
    Liston EH, Salk JD. Hemodynamic responses to ECT after bilateral adrenalectomy. Convuls. Ther. 1990; 6: 160164.
  • 36
    Saravanan ES, Gangadhar BN, Janakiramaiah N, Pandey RS, Murthy HS, Subbakrishna DK. Does higher cardiovascular response to ECT predict early antidepressant effect? J. Affect. Disord. 2002; 69: 101108.
  • 37
    Webb MC, Coffey CE, Saunders WR, Cress MM, Weiner RD, Sibert TR. Cardiovascular response to unilateral electroconvulsive therapy. Biol. Psychiatry 1990; 28: 758766.
  • 38
    O'Connor CJ, Rothenberg DM, Soble JS et al. The effect of esmolol pretreatment on the incidence of regional wall motion abnormalities during electroconvulsive therapy. Anesth. Analg. 1996; 82: 143147.
  • 39
    Messina AG, Paranicas M, Katz B, Markowitz J, Yao FS, Devereux RB. Effect of electroconvulsive therapy on the electrocardiogram and echocardiogram. Anesth. Analg. 1992; 75: 511514.
  • 40
    Green R, Woods A. Effects of modified E.C.T. on the electrocardiogram. Br. Med. J. 1955; 1: 15031505.